CELG-RI — BRISTOL MYERS SQUIBB CO

—
NYSE · Health Care · Pharmaceuticals · CIK 14272 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 12,973,000,000 9,247,000,000 -4,425,000,000 3,317,000,000 87,634,000,000 8,722,000,000 65,315,000,000
Mar 2026 11,489,000,000 8,068,000,000 -5,600,000,000 2,677,000,000 86,476,000,000 9,574,000,000 66,374,000,000
Sep 2025 12,222,000,000 8,787,000,000 -4,638,000,000 2,201,000,000 96,889,000,000 15,726,000,000 78,289,000,000
Jun 2025 12,269,000,000 8,897,000,000 -6,228,000,000 1,310,000,000 94,676,000,000 12,599,000,000 77,187,000,000

Annual Trend (SEC EDGAR, last 10y)

Revenues vs Net Income (last 10y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 48,194,000,000 -27,839,000,000 7,054,000,000 90,038,000,000 71,533,000,000 18,506,000,000 —
Dec 2024 48,300,000,000 -54,990,000,000 -8,948,000,000 92,603,000,000 76,215,000,000 16,388,000,000 —
Dec 2023 45,006,000,000 -29,849,000,000 8,025,000,000 95,159,000,000 65,674,000,000 29,485,000,000 —
Dec 2022 46,159,000,000 -30,650,000,000 6,327,000,000 96,820,000,000 65,702,000,000 31,118,000,000 —
Dec 2021 46,385,000,000 -32,820,000,000 6,994,000,000 109,314,000,000 73,308,000,000 36,006,000,000 —
Dec 2020 42,518,000,000 -48,053,000,000 -9,015,000,000 118,481,000,000 80,599,000,000 37,882,000,000 —
Dec 2019 26,145,000,000 -17,031,000,000 3,439,000,000 129,944,000,000 78,246,000,000 51,698,000,000 —
Dec 2018 22,561,000,000 -12,459,000,000 4,920,000,000 34,986,000,000 20,859,000,000 14,127,000,000 —
Dec 2017 20,776,000,000 -13,353,000,000 1,007,000,000 33,551,000,000 21,704,000,000 11,847,000,000 —
Dec 2016 19,427,000,000 -9,577,000,000 4,457,000,000 33,707,000,000 17,360,000,000 16,347,000,000 —

TTM Snapshot

Revenues TTM
$49,186,000,000
NetIncome TTM
$9,282,000,000
OpCashFlow TTM
—
Assets (Latest)
$87,634,000,000
Forward EPS
—

Peers — same industry

TickerNameMarket CapLastDaily %
LLY ELI LILLY & Co $1.26T $1415.55 —
JNJ JOHNSON & JOHNSON $670.92B $278.70 —
ABBV AbbVie Inc. $517.59B $292.82 —
MRK Merck & Co., Inc. $353.44B $143.37 —
NVS NOVARTIS AG $302.46B $159.13 —

News headlines (Yahoo Finance, 1h cache)

Evotec shares rise after second IND acceptance with Bristol Myers
2026-11-19 09:10 · Yahoo
Evotec and Bristol Myers Squibb Advance Strategic Protein Degradation Partnership with Second IND Acceptance
2026-11-19 07:06 · Yahoo
Exelixis Eyes Q1 Zanza Data as It Plans Beyond CABO
2026-11-19 03:12 · Yahoo
Bristol-Myers Squibb: 3 Key Takeaways for Long-Term Investors
2026-11-18 20:20 · Yahoo
Bristol Myers vs. Merck: Which Big Pharma Stock Is the Better Buy?
2026-11-18 18:11 · Yahoo
Missed Bristol-Myers Squibb's Rally? Here's What Early Buyers Saw
2026-11-18 17:11 · Yahoo
Altria or Bristol Myers Squibb: The One Dividend Stock I’d Hold for the Next 20 Years
2026-11-18 15:23 · Yahoo
Merck Ends Nemtabrutinib Development: What's Next for Its Pipeline?
2026-11-18 14:36 · Yahoo
Bristol Myers Squibb Presents First Clinical Data from Two Phase 3 Studies in the ADEPT Program Evaluating KarXT for Psychosis Associated with Alzheimer’s Disease
2026-11-18 14:10 · Yahoo
Bristol Myers Stock's Dividends Couldn't Close The Gap
2026-11-18 12:44 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.